See the DrugPatentWatch profile for yervoy

Who Qualifies for Yervoy Discounts: Understanding the Eligibility Criteria

Introduction

Yervoy, also known as ipilimumab, is a revolutionary immunotherapy medication used to treat various types of cancer, including melanoma, lung cancer, and kidney cancer. While it has shown significant promise in improving patient outcomes, it comes with a hefty price tag. As a result, many patients and healthcare providers are seeking ways to reduce the cost of Yervoy. In this article, we'll delve into who qualifies for Yervoy discounts and explore the eligibility criteria.

What is Yervoy?

Yervoy is a monoclonal antibody that works by boosting the body's immune system to fight cancer cells. It's administered intravenously every three weeks for up to four doses. Yervoy has been approved by the FDA for the treatment of unresectable or metastatic melanoma, and it's also being studied for its potential in treating other types of cancer.

Who Qualifies for Yervoy Discounts?

While Yervoy is a life-saving medication, its high cost can be a significant barrier for many patients. Fortunately, there are several ways to reduce the cost of Yervoy. Here are some groups of people who may qualify for Yervoy discounts:

Patients with Limited Income

Patients with limited income may be eligible for financial assistance programs offered by the manufacturer, Bristol-Myers Squibb. The company's Patient Assistance Program (PAP) provides free or reduced-cost Yervoy to eligible patients who are uninsured or underinsured.

Patients with Medicare or Medicaid

Patients with Medicare or Medicaid coverage may be eligible for Yervoy discounts through various programs. For example, the Medicare Part D Low-Income Subsidy (LIS) program helps eligible patients pay for their prescription medications, including Yervoy.

Patients with Commercial Insurance

Patients with commercial insurance may be eligible for Yervoy discounts through their insurance provider or a patient assistance program. For instance, the manufacturer's Copay Program offers a $10 copay for eligible patients with commercial insurance.

Patients with Rare or Orphan Diseases

Patients with rare or orphan diseases may be eligible for Yervoy discounts through programs specifically designed for these conditions. For example, the National Organization for Rare Disorders (NORD) offers a patient assistance program for patients with rare diseases.

How to Apply for Yervoy Discounts

Applying for Yervoy discounts can be a complex and time-consuming process. Here are some steps to help you get started:

Contact the Manufacturer's Patient Assistance Program

Patients can contact the manufacturer's Patient Assistance Program (PAP) to see if they're eligible for financial assistance. The PAP can be reached at 1-888-423-3578 or www.bms.com/patient-assistance-program.

Check with Your Insurance Provider

Patients with commercial insurance should contact their insurance provider to see if they offer any discounts or copay programs for Yervoy.

Explore Non-Profit Organizations

Non-profit organizations, such as the Patient Access Network Foundation (PAN) and the HealthWell Foundation, offer financial assistance programs for patients with chronic diseases, including cancer.

Use Online Resources

Online resources, such as DrugPatentWatch.com, can help patients find information on Yervoy discounts and financial assistance programs.

Conclusion

Yervoy is a life-saving medication that has shown significant promise in treating various types of cancer. While its high cost can be a significant barrier for many patients, there are several ways to reduce the cost of Yervoy. By understanding who qualifies for Yervoy discounts and exploring the eligibility criteria, patients and healthcare providers can work together to make this medication more accessible.

Key Takeaways

* Patients with limited income may be eligible for financial assistance programs offered by the manufacturer.
* Patients with Medicare or Medicaid coverage may be eligible for Yervoy discounts through various programs.
* Patients with commercial insurance may be eligible for Yervoy discounts through their insurance provider or a patient assistance program.
* Patients with rare or orphan diseases may be eligible for Yervoy discounts through programs specifically designed for these conditions.
* Applying for Yervoy discounts can be a complex and time-consuming process, but it's worth exploring to make this medication more affordable.

FAQs

1. Q: Who is eligible for the Yervoy Patient Assistance Program?
A: Patients who are uninsured or underinsured and have limited income may be eligible for the Yervoy Patient Assistance Program.

2. Q: Can patients with commercial insurance apply for Yervoy discounts?
A: Yes, patients with commercial insurance may be eligible for Yervoy discounts through their insurance provider or a patient assistance program.

3. Q: How do I apply for Yervoy discounts?
A: Patients can apply for Yervoy discounts by contacting the manufacturer's Patient Assistance Program, checking with their insurance provider, exploring non-profit organizations, and using online resources.

4. Q: Are there any online resources that can help me find Yervoy discounts?
A: Yes, online resources such as DrugPatentWatch.com can help patients find information on Yervoy discounts and financial assistance programs.

5. Q: Can patients with rare or orphan diseases apply for Yervoy discounts?
A: Yes, patients with rare or orphan diseases may be eligible for Yervoy discounts through programs specifically designed for these conditions.

Sources

1. Bristol-Myers Squibb. (n.d.). Patient Assistance Program. Retrieved from <https://www.bms.com/patient-assistance-program>
2. DrugPatentWatch.com. (n.d.). Yervoy (ipilimumab). Retrieved from <https://www.drugpatentwatch.com/drug/yervoy-ipilimumab>
3. National Organization for Rare Disorders. (n.d.). Patient Assistance Program. Retrieved from <https://rarediseases.org/patient-assistance-program/>
4. Patient Access Network Foundation. (n.d.). Yervoy (ipilimumab). Retrieved from <https://www.panfoundation.org/programs/yervoy-ipilimumab>
5. HealthWell Foundation. (n.d.). Yervoy (ipilimumab). Retrieved from <https://www.healthwellfoundation.org/programs/yervoy-ipilimumab>